Bliss GVS Pharma Ltd
BLISSGVSBliss GVS Pharma Ltd
BLISSGVS
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 15.48 | 1.01 | 0.56% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 39.72 | 4.66 | 0.78% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 427.42 | 571.24 | 810.94 | 841.18 | 936.20 | 728.50 | 597.43 | 778.94 | 769.38 | 738.33 | ||||||||||
Raw Materials | 173.90 | 262.55 | 368.69 | 391.70 | 618.79 | 435.67 | 341.59 | 420.18 | 374.38 | 619.76 | ||||||||||
| Power & Fuel Cost | 4.36 | 4.72 | 5.58 | 5.49 | 4.76 | 5.88 | 8.14 | 8.25 | 7.13 | |||||||||||
| Employee Cost | 29.43 | 33.74 | 61.35 | 69.23 | 42.32 | 53.69 | 68.09 | 76.15 | 86.17 | |||||||||||
| Selling & Administrative Expenses | 64.12 | 67.19 | 117.90 | 87.57 | 49.96 | 45.30 | 44.91 | 80.65 | 78.55 | |||||||||||
| Operating & Other expenses | 31.89 | 22.98 | 42.19 | 97.72 | 25.10 | 38.83 | 7.82 | 117.48 | 88.03 | |||||||||||
EBITDA | 123.72 | 180.06 | 215.23 | 189.47 | 195.27 | 149.13 | 126.88 | 76.23 | 135.12 | 118.57 | ||||||||||
| Depreciation/Amortization | 11.30 | 13.26 | 20.14 | 21.38 | 8.94 | 12.59 | 17.23 | 17.33 | 18.67 | 20.31 | ||||||||||
| PBIT | 112.42 | 166.80 | 195.09 | 168.09 | 186.33 | 136.54 | 109.65 | 58.90 | 116.45 | 98.26 | ||||||||||
| Interest & Other Items | 16.41 | 18.61 | 19.69 | 22.80 | 4.41 | 7.57 | 5.51 | 4.74 | 10.36 | 9.74 | ||||||||||
| PBT | 96.01 | 148.19 | 175.40 | 145.29 | 181.92 | 128.97 | 104.14 | 54.16 | 106.09 | 88.52 | ||||||||||
| Taxes & Other Items | 36.10 | 65.71 | 93.36 | 86.51 | 58.19 | 31.71 | 35.63 | 39.13 | 35.22 | 28.72 | ||||||||||
| Net Income | 59.91 | 82.48 | 82.04 | 58.78 | 123.73 | 97.26 | 68.51 | 15.03 | 70.87 | 59.80 | ||||||||||
| EPS | 5.81 | 8.00 | 7.95 | 5.70 | 12.00 | 9.43 | 6.64 | 1.45 | 6.82 | 5.74 | ||||||||||
| DPS | 0.70 | 0.50 | 0.60 | 1.00 | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.00 | ||||||||||
| Payout ratio | 0.12 | 0.06 | 0.08 | 0.18 | 0.08 | 0.05 | 0.08 | 0.34 | 0.07 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bliss GVS Pharma Ltd | 13.06 | 1.01 | 0.56% |
| Sun Pharmaceutical Industries Ltd | 32.06 | 4.58 | 1.02% |
| Cipla Ltd | 33.54 | 3.96 | 0.73% |
| Dr Reddy's Laboratories Ltd | 20.05 | 3.88 | 0.74% |
Price Comparison
Compare BLISSGVS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 0.56%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.63 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 12, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Jul 12, 2023
Cash Dividend
Ex DateEx DateJun 20, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jun 20, 2022
Cash Dividend
Ex DateEx DateSep 13, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 13, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2020
Cash Dividend
Ex DateEx DateSep 12, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Sep 12, 2019
News & Opinions
Bliss GVS Pharma declines after Palghar units gets Form 483 with 3 observations from US FDA
6 months ago•Business Standard
Bliss GVS Pharma share price falls on observations from USFDA
6 months ago•Moneycontrol
MRO-TEK Realty Ltd leads gainers in ‘B’ group
8 months ago•Business Standard
Bliss GVS Pharma reports consolidated net profit of Rs 27.94 crore in the December 2022 quarter
8 months ago•Business Standard
Bliss GVS Pharma consolidated net profit declines 34.88% in the September 2022 quarter
10 months ago•Business Standard
Bliss GVS Pharma consolidated net profit rises 6.06% in the June 2022 quarter
1 year ago•Business Standard
ITI Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -1.77%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.41% to 0.24%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 3.81%, vs industry avg of 9.81%